Related Experiment Video
Updated: Sep 4, 2025

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019
Compromised blood-bile barrier after acetaminophen overdose
Aya A Abbas1, Amira Hamdy1, Ahmed Ezzat Ahmed2,3
1Forensic Medicine and Toxicology Department, Faculty of Veterinary Medicine, South Valley University, Qena, 83523, Egypt.
Acetaminophen (APAP) overdose causes liver injury by increasing toxic bile acids in liver cells. Inhibiting bile acid uptake offers a new therapeutic strategy beyond N-acetylcysteine.
Area of Science:
- Hepatology
- Toxicology
- Biochemistry
Background:
- Acetaminophen (APAP) overdose is a leading cause of acute liver failure.
- N-acetylcysteine (NAC) is the sole approved antidote but has a narrow therapeutic window.
- Patients often present for treatment outside the efficacy window of NAC.
Discussion:
- APAP intoxication induces hepatotoxicity through a novel mechanism involving intracellular bile acid accumulation.
- APAP disrupts bile canaliculi tight junctions, causing bile acid leakage into sinusoids.
- Hepatocytes reabsorb leaked bile acids, leading to cytotoxic intracellular concentrations and cell death.
Key Insights:
- Inhibiting bile acid uptake carriers significantly reduces intracellular bile acid levels.
- Blocking bile acid reuptake ameliorates APAP-induced hepatotoxicity in preclinical models.
- This mechanism reveals a new therapeutic target for APAP poisoning.
Outlook:
- Targeting bile acid transport pathways presents a promising new therapeutic avenue.
- Developing inhibitors of bile acid uptake could overcome NAC's limitations.
- Further research may lead to novel treatments for acetaminophen poisoning.
More Related Videos
10:40Visualization and Analysis of Blood Flow and Oxygen Consumption in Hepatic Microcirculation: Application to an Acute Hepatitis Model
Published on: August 4, 2012
08:59An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
Published on: December 3, 2020
Related Concept Videos
Hepatic Drug Excretion: Influencing Factors
Hepatic Drug Excretion: Enterohepatic Cycling
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Enhanced Elimination of Poison
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Prevention of Further Absorption of Poison
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
Several distinctive characteristics distinguish glutathione conjugation from other phase II...